V VETTER
DEAD

Serial Number

76300711

Owner

ARZNEIMITTEL GMBH APOTHEKER VETTER & CO. RAVENSBURG

Attorney

HERBERT DUBNO

First Use Date

Sep 25, 2003

Filing Date

Aug 15, 2001

Add to watchlist:

No watchlists yet
View on USPTO

V VETTER Trademark

Serial Number: 76300711 • Registration: 3036124

V VETTER is a trademark filed by ARZNEIMITTEL GMBH APOTHEKER VETTER & CO. RAVENSBURG on August 15, 2001. The trademark is classified under Class 5 (Pharmaceuticals), Class 7 (Machinery), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

ARZNEIMITTEL GMBH APOTHEKER VETTER & CO. RAVENSBURG (23 trademarks)

IM KAMMERBRUHL 24
Ravensburg D-88212 , DE

Entity Type: 03

Trademark Details

Filing Date

August 15, 2001

Registration Date

December 27, 2005

First Use Anywhere

September 25, 2003

First Use in Commerce

September 25, 2003

Published for Opposition

January 14, 2003

Cancellation Date

August 3, 2012

Goods & Services

Machine tools, motors, couplings and clutches, drive belts, filling machines, labelling machines packaging machines, box-making machines for erecting, filling and closing of cardboard and foldable boxes; machines for washing, filling and closing containers, namely medical syringes and vials, robots, mechanical transport machines for the transfer of containers between processing stations, and thermoforming machines for producing, filling and sealing of blister packaging; and machines for controlling the supply and filling of goods in containers

Pharmaceutical products and medicaments, solutions for oral use, sterile solutions in forms suitable for sale and/or for application and solutions for injections; all for use in the treatment of infections, cancer, depression, heart disease, vascular disease, kidney disease, intestinal disorder, lung and bronchial disorder, liver dysfunction, oral and laryngeal disease, optical and cranial disorders, and preparations containing heparins, vaccines, calcitonins, prostaglandins, anaesthestics, reconstruction diluents, human growth hormone, monoclonal antibodies, epo, urokinse, factor VIII, gnrh analogs, and recombinant proteins eye drops, solutions for contact lenses; fillings of liquid, semi-solid or solid substances, namely pharmaceutical products in solvated form as solutions with active agents, as powders with solvent or as lyophilistates with solvent in injection systems, namely, in injection syringes and instruments for infections, injectors, injector pens as well as in single chamber, double chamber and disposable syringes, as well as solutions for oral use as well as sterile solutions suitable for sale and /or for application, solutions for injections including aseptic filling of injection solutions all for use in the treatment of infections, cancer, depression, heart disease, vascular disease, kidney disease, intestinal disorder, lung and bronchial disorder, liver dysfunction, oral and laryngeal disease, optical and cranial disorders, and preparations containing heparins, vaccines, calcitonins, prostaglandins, anaesthestics, reconstruction diluents, human growth hormone, monoclonal antibodies, epo, urokinase, factor VIII, gnrh analogs, and recombinant proteins, manufactured objects and products for medical and medical-technical use, namely tampons with and without disinfectants and bandages separately or jointly packed, and in sterile packages

Medical injection systems, namely syringes and instruments for injections, injectors, injection pens auto-injectors as well as single chamber and double chamber disposable syringes, all sold empty, containers for medicaments made from glass and/or plastics and syringe holders for ready-to-use syringes for picking-up and handling of syringes

Development of injection syringes and instruments and injectors and corresponding packages; chemical, physical and procedural examinations as well as microbiological examinations also as paid service for third parties

Filing History

CANCELLED SEC. 8 (6-YR)
Aug 3, 2012 C8..
REGISTERED-PRINCIPAL REGISTER
Dec 27, 2005 R.PR
LAW OFFICE REGISTRATION REVIEW COMPLETED
Nov 16, 2005 REGV
ASSIGNED TO LIE
Nov 10, 2005 ALIE
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Nov 9, 2005 CNPR
AMENDMENT FROM APPLICANT ENTERED
Oct 17, 2005 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 3, 2005 CRFA
PAPER RECEIVED
Oct 3, 2005 MAIL
NON-FINAL ACTION MAILED
Mar 31, 2005 CNRT
SU - NON-FINAL ACTION - WRITTEN
Mar 31, 2005 CNRT
STATEMENT OF USE PROCESSING COMPLETE
Oct 25, 2004 SUPC
USE AMENDMENT FILED
Oct 8, 2004 IUAF
TEAS STATEMENT OF USE RECEIVED
Oct 8, 2004 EISU
SOU EXTENSION 2 GRANTED
Apr 20, 2004 EX2G
CASE FILE IN TICRS
Apr 16, 2004 CFIT
SOU EXTENSION 2 FILED
Apr 7, 2004 EXT2
SOU TEAS EXTENSION RECEIVED
Apr 7, 2004 EEXT
SOU EXTENSION 1 GRANTED
Oct 15, 2003 EX1G
SOU EXTENSION 1 FILED
Oct 7, 2003 EXT1
SOU TEAS EXTENSION RECEIVED
Oct 7, 2003 EEXT
NOA MAILED - SOU REQUIRED FROM APPLICANT
Apr 8, 2003 NOAM
PUBLISHED FOR OPPOSITION
Jan 14, 2003 PUBO
NOTICE OF PUBLICATION
Dec 25, 2002 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 12, 2002 CNSA
SEC. 44(D) CLAIM DELETED
Oct 15, 2002 44DD
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 15, 2002 CRFA
PAPER RECEIVED
Oct 15, 2002 MAIL
LETTER OF SUSPENSION MAILED
Apr 17, 2002 CNSL
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 6, 2001 CRFA
NON-FINAL ACTION MAILED
Oct 11, 2001 CNRT
ASSIGNED TO EXAMINER
Sep 24, 2001 DOCK
ASSIGNED TO EXAMINER
Sep 20, 2001 DOCK